Is Neptune Bio a state-owned enterprise?

Judging from the current announcements of "mixed ownership reform" and "introduction of strategic investors", it means that the company may introduce state-owned assets, and the specific plan needs further disclosure by the company. Generally speaking, state-owned investment institutions shoulder the mission of maintaining and increasing the value of state-owned assets. Participating in the mixed reform of enterprises means that the value of the company has been recognized by state-owned investment institutions, and it also reflects the confidence of the capital market in the future development of the company and the pharmaceutical industry.

Shenzhen Wanghai Bioengineering Co., Ltd. was established in 1992, and it is a large-scale pharmaceutical listed company with pharmaceutical research and development, pharmaceutical commercial circulation, pharmaceutical retail chain and pharmaceutical industry as its core business. At present, the company's income is mainly concentrated in two parts: pharmaceutical circulation and medical equipment. According to the performance forecast of 20021disclosed by the company, it is estimated that the net profit attributable to shareholders of listed companies in 20021is 60 million yuan to 85 million yuan, and the company's operating income has increased compared with the same period of last year, turning losses into profits.